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Lrst of Figures
Figure 1. Electron micrograph of a depleted appearing cell
characteristic of the majority of lymphocytes of
this subject.
Figure 2. Electron micrograph of a more "normal" appearing
lymphocyte developed following administration of
transfer factor.
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FigureS. Incorporation of H-thymidine into peripheral blood
lymphocytes of subjects inoculated with Influenza A
vaccine.
Figure 4. Blastogenic response of volunteers inoculated with
Influenza A Hong Kong strain.
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"Prodromal Disease: Immune Responses of the
Host Macrophage System to Humoral Factors"
I. S ummary.
The following report is a composite of nine studies, each yielding
information contributing toward an understanding of methods designed to
detect disease during the prodromal stages. The data further point to
new areas of study that might be useful in early diagnoses.
Five of the nine experiments were done in mice. Four of these
involved acute infectious disease states and one involved a chronic
autoimmune type disease. Of the numerous perimeters studied of the
acute diseases, the uptake of ^H-thymidine by peripheral blood lympho-
cytes appeared to yield the earliest indication of disease. This test
was not useful in studying the chronic disease state.
Four of the nine studies involved application of diagnostic technics
to human disease. A normal baseline for ^H-thymidine incorporation by
human lymphocytes was determined. A subject with severe combined.
immunodeficiency disease was studied. A human volunteer study was
done using Influenza A live attenuated vaccine. Finally, a human
volunteer study of subjects infected with Influenza A was done.
II. Introduction:
The lymphocyte appears to be the primary cell responsible for production
of specific antibodies directed against all disease agents (Lawrence and
Landy, 1969). To produce antibody, the lymphocyte must undergo a series
of changes. It first must become stimulated, a condition that may be enhanced
by contact with other cells such as macrophages. Following stimulation,
the lymphocyte must synthesize new DNA, RNA, and possibly specific
proteins that will lead either to division of the lymphocyte or antibody
production. The uptake of ^H-thymidine by lymphocytes would indicate
synthesis of new DNA in these cells.
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Hersh et al_.(1970) first described the use of H-thymidine uptake as
an early detection device used to assay the lymphocyte response in transplant
patients. They showed that this test procedure might be useful to predict
early rejection in heart recipients. The present report has extended their
observations to include infectious diseases, specifically mice infected with
P. berghei, !D. pneumoniae, IE. coli B, and Hemophilus iqfluenzae. In
all cases thelymphocytes showed an increased uptake of -^H-thymidine
before the disease was detected by any other means.
Mice with _P. berg he i infection generally show a parasitemia as
their first evidence of disease. The time of detection of this
parasitemia depends upon the number of parasitized cells that these
animals receive. As the numbers decrease, the day of onset is
extended. In all cases the duration of disease following onset lasts
9 to 12 days. The ^H-thymidine incorporation increases at 2_days,
thus preceding , any other means of detection.
The LDH isoenzymes have classically been used as indicators
of early tissue destruction. In malarial infection, these enzymes
were so sporadic in quantitative responses until they appeared quite
unreliable as an early detection device.
Mice infected with IE. col^ were studied. The thymidine response
was again compared with the LDH isoenzyme III response seen to rise
at 18 hours. The LDH rise was consistent and significant for 18
hours but returned to non-significant values by 24 hours. The
thymidine response continued to increase. The elevation in percentages
of neutrophils probably reflected the animal's cellular response to rid
the body of bacteria. E_. coli disappeared from the blood stream by
48 hours, corresponding to the time the percentage of neutrophils
returned to the normal range.
In mice infected with D. pneumoniae the infection was so fulminating
that only the lymphocytes responded before death in the animals. Fever
and clinical symptoms were noted 6 hours following the rise in ^H-
thymidine uptake by lymphocytes.
The above three studies may be found in detail in the progress
report submitted previously (Criswell, 1970).
H_. influenza produces pneumonia in mice characterized by an infiltrate
in the lungs. This disease is fatal if high concentrations of the organisms
are used. The dosage was chosen to produce disease but not death.
Again the most rapidly detectible means of disease was the ^H-thymidine
incorporation by the lymphocytes. Detailed studies will be presented later
in this report.
In each of the preceding cases the disease state was acute and
had no long term implications. Malaria in mice, as stated, is fatal
if contracted. To look at possible detection methods in chronic disease
a serial study was undertaken to study glomerulonephritis in mice.
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H-thymidine incorporation was not a useful means in studying
this disease because of its chronic nature. This study was
coordinated through Dr. J. M. Holland at JSC. Detailed reports
are attached (Appendix I, II, III/ IV, & V)« Immunoglobulin
deposits on the surfaces of glomeruli were detected by fluorescent
antibody. The age of the animals correlated well with the severity
of disease and the amount of immunoglobulin found on the surfaces
of the glomeruli. The immunoglobulin accumulation appeared to give
a good indication of future chronic disease in these animals.
To extend the tests developed for the mice to a human population,
four studies were done. (1) A normal baseline for ^H-thymidine
incorporation into peripheral lymphocytes was established for 71
subjects. The mean values and statistical variations were determined.
(2) An immunodeficient subject was studied extensively. (3) A
human volunteer study was done using Influenza A live attenuated
vaccine. (4) A human volunteer study of subjects infected with
Influenza A (Hong Kong strain live and virulent) was done.
III. -Methods and Materiais.
/;< All methods are recorded in Appendix VI that were used for any
study in this report. Procedural approaches will be given with each
individual study in the following section. .
IV. Individual Studies.
A. Mice infected with _P. berghei, |E. coli B, and D. pneumonia:
These studies have been reported .previously inHetaih
(Criswell, 1970).
B. Mice infected with Hemophilus influenza:
Procedure: A test group of normal C-57 mice were injected
(I.P.) at 0 hour with H. influenza in a dosage of 1.0 X 108 cells.
Blood samples were drawn at 6 hr intervals. The lymphocytes were
separated by the.alass bead column method and subjected to a low
concentration of H-thymidine. Control (non-infected mice) were also
drawn at each period.
Results and Discussion: The results which were assayed by
scintillation counting showed no increase in ^H-thymidine uptake until
the 18th hour after injection from which there was a notable steady
increase up to 30 hours and a decline thereafter to 48 hours after
injection.
The mice showed no visible sign of illness although the increase
observed in ^H-thymidine by the lymphocytes points out that there was
a definite effect of the organism upon the test lymphocytes. The
consistently low baseline of the control mice supports this observation.
Total white counts rose also indicating infection in the test animals.
Again the ^H-thymidine incorporation into m vivo responding lymphocytes
appears to be a useful test for early detection of bacterial infection.
C. Mice with Chronic Glomerulonephrit is:
Individual reports are found in detail as Appendix I, II, III,
IV and V.
3D. Human Studies - Normal Baselines for H-thymidine Incorporation
by Peripheral Blood Lymphocytes:
Procedure: Lymphocytes from 10 ml heparinized blood were
separated by use of the Technicon Separator. 10° cells were incubated
with ^H-thymidine for a two hour period and then the nucleoprotein
incorporation rates determined.
Results: The indiv idual values are shown in Table I. The
mean value was 40 cpm with a S .D« of 11 cpm. Establishment of
such baseline data w i l l allow future comparisons with that from known
infected cases.
E. Human Studies - An Immunodeficient Subject:
Procedure: Heparinized blood was obtained from an infant with
severe combined immune deficiency. The ind iv idua l was maintained in a
germ free condition from birth to the present time. The individual was
followed at monthly intervals for approximately 18 mo. The blood was
spun at 2500 g for 2 min to obtain a buffy coat. The buffy coat was
washed three times in PBS (pH = 7.4) and then subjected to various
analyses. Wright's stained smears were examined for morphology of
cells. Cells were stained with fluorescein-tagged anti-human gamma
g l o b u l i n (polyvalent, IgA, IgM, or IgG) for determination of B (bone
marrow dependent) and T (thymic dependent) lymphocytes. Slides were
made on some preparations for analysis by microspectrophotometry. Cells
were fixed also for electron microscopy. Plasma was analyzed for immuno-
globul in levels. Cells were cultured and stimulated with PHA, Pokeweed,
and Streptolysin 0 to determine blastogenesis. DNA/RNA ratios were run
using cytofluorometry determinations of acridine orange stained cells. All
f indings were compared with normal control values obtained from either
chi ldren the same age or cells of known reactivity.
TABLE I
NORMAL.LYMPHOCYTE STUDIES
(3H-Thy mi dine Uptake)
Sample No-
1
3
5
6
7
8
9
10
11
12
15
16
18
19
21
22
23
24
28
29
47
48
49
50
51
52
Initials
C.G.
P.O.
WoJ.
H.L.
B.H.
R.Ho
LoL.
R.P.
J.L.
N.J.
Y.
R.B.
H.J.
F.R.
A.B.
R.B.
J.W.
J.R.
CeP.
B.H.
J.W. .
H.C.
L.M.
T.No
O o w •
C.M.
Cts./min.
(mean)
44
50
40
30
23
41
62
49
51
41
55
44
36
52
72
59
46
47
83
57
43
42
55
38
34
37
TABLE 1 CON'T
Sample No.
i
53
54
55
57
58
59
60
62
63
64
65
67
68
70
71
72
76
9.2
95
97
9.8
99
100
104
105
107
111
113
115
Initials
D.Co
C.H.
J.R.
J..N.
R.W.
M.S.
V.J.
R.M.
S.W.
D.G.
P.K.
J.B.
H.
J..K.
R.S..
T.S.
K.S.
J.B.
D.C.
R.K.
L.W.
MoP.
R.H.
B.Mo
M.L.
E.B.
C.D.
R.V=
R.E.
Cts./min.
(mean) '
.43
31
33
29
47
33
32
39
42
32
30
64
32
44
38
28
39
49
44
43
56
33
37
40
45
60
37 .
27
55
TABLE 1 CON'T
Sample No.
116
117
126
128
129
130
131
133
134
138
142
146
148
150
153
157
Initials
D.R.
J.T.
J.D.
R.Jo
: S.H.
R.R.
T.M. .
PcMo
D.P.
D.Po
C.Mo
M.Po
CoG.
A.F.
M o L o
R.Lo
Cts./min.
(mean)
22
37
36
35
29
40
53
32
35
3.6
43
48
30
81
24
110
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Results and Discussion:
1. Morphological Results.
a. Light Microscopic Findings:
At 6 weeks of age, large lymphocytes with light staining nuclei
were observed in peripheral blood smears. The cells were definitely
atypical with little nuclear density and very little nuclear cytoplasmic
contrast. A very few small "normal" appearing lymphocytes with dark
nuclei without nucleoli were seen in some fields. Of 100 lymphocytes
counted 91 were 10 p. or larger, they had markedly heterogeneity of
nuclear staining, 2 or more nucleoli were present, cytoplasmic vacuoles
were present, and the nuclear/cytoplasmic ratio appeared small. Nine
of the 100 cells were <10 p in size with a nuclear size <9 y., the
nuclear staining was slightly heterogeneous, nucleoli of 0 or 1 were
present, cytoplasmic vacuoles were absent, and the nuclear/cytoplasmic
ratio was large. Following an injection with tetanus toxoid the ratio
at the end of 1 month changed to 28% small lymphocytes and 72% large
lymphocytes.
b. Electron Microscopic Observations:
For findings see Abstract attached in Appendix VII. Fig. 1 and 2_
demonstrate the two cell types found. Figure 1^ shows the depleted ~~
appearing cell while Fig. 2_ shows the newer population of cell appearing
at the same time as transfer factor was given.
2. B/T Cell Ratios.
On unseparated samples of buffy coat the B cell population
was determined to be 96% of the circulating lymphocytes. Of this group
of cells 8% contained IgA, 54%, IgG, and 48%, IgM on the cell surfaces.
Technicon separated samples of blood showed only 42% lymphocytes. These
ratios point to the marked thymic or T cell deficiency.
3. IMucleoprotein Analyses:
a. Microspectrophotometry:
Refer to Appendix VIII for Abstract on findings.
Figure 1. Electron micrograph of a depleted appearing
cell characteristic of the majority of
lymphocytes of this subject.
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Figure 2. Electron micrograph of a more "normal"
appearing lymphocyte developed following
administration of transfer factor.
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6.
b« Acridine Orange binding capacity:
The lymphocytes of this subject were determined to have the
same binding capacities for A.O. as normal adult lymphocytes
indicating that the DNA/RNA content of these cells is normal.
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4. Blastogenic Response Determined by H-thymidine
Incorporation.
. No stimulation with any specific or non-specific mitogen has
been recorded.
5. Plasma Immunoglobulin Levels.
Table II shows the immunoglobulin levels during the 18 mo. period.
Very small quantities of Ig were produced further indicating the severe
combined immunodeficiency.
F. Human Studies: A volunteer Study of Subjects Immunized
with Influenza A live Attenuated Vaccine.
Procedure: Six laboratory workers who were to be immunized
with the flu vaccine were studied on days -1, 0, 1, 2, 3 and 6.
Vaccination was given on day 0. Peripheral blood lymphocytes were
obtained by the Technicon Separator Method. 10" lymphocytes were
examined for H-thymidine uptake following separation.
Results and Discussion: Figure 3 shows the findings.
All subjects experienced a febrile reaction approximately 4-24 hrs
following vaccination. None had lasting clinical symptoms. Neutralizing
antibody titers were not run on the subjects prior to immunization;
therefore, prior contact with the virus was not eliminated. As can be
seen all subjects initially dropped or showed little significant change.
The important contrast to previous data found in animals is that no initial
early rise is seen in ^H-thymidine incorporation in this viral infection.
For this reason the following volunteer study, made possible through
cooperative studies already in progress at Baylor College of Medicine-,
was done usina a virulent viral strain, | Since no initial increases
were seen in 3H-thymidine studies in this initial study, the lymphocytes
were cultured in the subsequent study.
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Figure 3. Incorporation rates of ^H-thymldine into
peripheral blood lymphocytes of subjects
inoculated with Influenza A Vaccine.
Key: Subject 1 a Lower Graph
2 O -
3 A - - -
4 •*-
• . '
Subject 5 if Top Graph
6 0> '
7 P
E>
B-l.
ED.
•8
OTO
6 8
CD.
8
mvs
s 8
7.
:
. . - G. . Human Studies - A Human Volunteer Study with Influenza A,
Hong Kong Strain.
Procedure: 5 ml heparinized blood was obtained from 9
subjects infected with Influenza A by intranasal instillation. Blood
samples were obtained on Day 0 before inoculation and on Days 4,
5, and 13 after inoculation. Lymphocytes were separated from the
blood by use of a Techm'con Lymphocyte Separator and were put into
culture with PHA and Pokeweed mitogens to determine the effect of a
viral infection on blastogenesis.
Results and Discussion: Figure 4 shows the results. The
stimulation index (stimulated lymphocytes cpm/unstimulated lymphocytes
cpm) is plotted for days 4 and 5 following inoculation for PHA cultures.
All men except #1 decreased in stimulation index for PHA responses on
day 5. By day 13 all subjects had again risen to values equal or
greater than the day 4 stimulation index. This drop is consistent with
previously published studies. It occurs about the same time as clinical
symptoms appear. This change could be of value if one could find a
way to examine cultured lymphocytes and detect the change prior to the
3 days required to run this test in the laboratory.
An obvious extension of this type study is to look at other properties
of lymphocytes for early changes such as surface immunoglobulins,
responses to the specific viral antigen itself when added to culture/
and further examine the culture procedure itself for changes occurring as
early as 3 or 4 hrs after adding an antigen to culture.
Figure 4. Blastogenic response of volunteers inoculated
with Influenza A Hong Kong virulent strain.
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ABSTRACT
By immunofluorescent techniques, four CD-I mice were found
to be in the moderate to severe stages of an autoimmune-like glomerulo-
nephritis 17 months after receiving Apollo 12 lunar material. Five\
control animals displayed evidence of a mild to moderate disease
state.
INTRODUCTION
Many strains of mice are predisposed to the development of
specific diseases in their old age. Among these examples are mice
that develop leukemia, tumors, and such autoimmune diseases as
hemolytic anemias (1). The germ-free CD-I Charles Rivers mice
are not characterized for development of such diseases but may indeed
be one of the strains that develop auto-immune type lesions.
Fresh tissues (kidney, liver, and spleens) from 18 mo. old
CD-I mice (Charles Rivers) were examined by immunofluorescent
techniques. Four of the nine mice examined had received Apollo 12
lunar materials. The glomeruli of the kidneys of all the 18 mo.
old animals showed a strong fluorescence when reacted with goat
anti-mouse gamma globulin. The glomeruli from the older animals
resemble those glomeruli of an autoimmune disease (1). Because of
such small numbers, definitive conclusions could not be drawn as
to the effect of the lunar materials upon the apparent disease state.
One month old CD-I mice were examined and showed no immuno-
fluorescence in the glomeruli.
METHODS AND MATERIALS
Tissues from the CD-I mice that received lunar material in
the Apollo 12 quarantine study were obtained from Dr. J. M. Holland,
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coordinator of the mammalian animal quarantine protocol- Frozen
sections of spleen, liver, and kidney were examined for fluorescence
following reaction with goat anti-mouse gamma globulin. For
controls 1 month old CD-I germ-free mice were also examined.
The procedure for direct staining was described by Weir (2) with
the exception of three 5 minute periods for washing slides. Photo-
graphs were taken on a Leitz Orthomat photomicroscope with the aid
of the Leitz automatic camera. Exciter filters UG 1 and BG 12 were
used.
RESULTS
All the 18 mo. old mice show signs of kidney disease. The
glomeruli of these animals fluoresced brightly following reaction with
anti-mouse gamma globulin (Fig. 1 and 2). The kidneys examined
show various stages of illness as indicated by the size of the
glomeruli and presence of an amorphous substance. Fig. 1 shows the
condition of mouse No. 642 which did not receive lunar material„
A fluorescent glomerulous that has not enlarged appreciably in size
and is intact in appearance is seen. The tubular areas have
essentially no materials within their lumens indicating a relatively
intact kidney* In contrast, Fig. 2 shows one of the most progressive
Fig. 1. Glomeruli from an 18 month old CD-I mouse
No. 642 that had received no lunar material
A/ /IS/) PAofo AJ.3- S -7 / - 4/42-0
Fig. 2. Glomeruli from an 18 month old CD-I mouse
No. 562 that had received lunar material
fo No. $'?}
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disease states seen in mouse No. 562 which received Apollo 12
lunar material. Thickened basement membranes of greatly enlarged
glomeruli filled with an amorphous material are seen. The tubules
contain gamma globulins, indicating loss in normal kidney function.
Fig. 3 shows tissue from CD 1 germ-free 4 month old animals.
No fluorescence is found.
Three stages of disease are apparent and are described in
Table 1.
TABLE 1
Conditions of Glomeruli Examined by Immunofluorescence Techniques
States of Disease
Category I Category II Category III
Animals receiving 642 639
no lunar rock 634 633
636
Animals receiving
lunar rock 531 565
532* 562
*532 had a hemolytic anemia in addition to the glomerulonephritis.
The animals classified as Category I, least effected, had
fluorescent labelled glomeruli that were intact with no enlargement,
no appreciable thickening of the basement membranes and minimal if
any amorphous material present. Category II, the moderately effected
Fig. 3. Kidney tissue from 4 month old germ free
CD-I mice
-f-o No, S- 71-
(
i
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group, had slightly enlarged, but still intact, glomeruli. Some •
amorphous infiltrate was apparent. The two mice in Category III I
were the most severely effected. They displayed large increases j
i
in size of the giomemli, some of which were no longer intact. j
. i
Convolutions were essentially gone, and massive amounts of the jii
amorphous infiltrate were present. In these two animals, the j
tI
infiltrate, along with fluorescent foci of immunoglobulin producing 1
cells, was present in the spleen and liver tissues as well as the
kidney.
!
DISCUSSION
The present study indicates that an autoimmune-like • . j
glomerulonephritis was present in both 18 mo. old control and
test animals of the Apollo 12 mice. The severity of the disease . j
varied among the different animals; however, since only 9 animals }
i
were examined, definitive conclusions concerning the lunar material's j
i
effect upon the underlying disease could not be determined., Animals j
receiving the added irritation of the lunar materials appeared to progress
more rapidly in their disease states than the controls. However, j
since no baseline studies exist for purposes of comparison and no
statistical variations are available, any conclusions can be only
speculation.
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The effects seen in these animals need to be characterized
further using more defined systems with larger numbers of animals
for statistical analyses. The effects of lunar material upon
autoimmune phenomenon or upon chronic disease states have not
been defined. Furthermore, comparisons should also be made for
effects seen when simulated lunar materials are used as an added
control for the lunar materials injected into animals.
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ABSTRACT
Kidney tissues from mice that were 15 mo old and had received
no previous injections were examined by immunofluorescent
techniques. 87% of these uninjected animals showed positive
immunofluorescence or immunoglobulin on their glomeruli. None
of the 57 animals examined possessed disease states as
severe as previously seen in the 17 mo Apollo 12 lunar
injected mice.
INTRODUCTION
Previous studies (Report # 1) indicated that CD-I Charles
Rivers mice examined 17 months after receiving injections of
lunar material might display enhanced severity of the
glomerulonephritis characteristic of aging mice. Since
the CD-I mice had not been characterized for such lesions,
a series of control animals are being studied to establish
a baseline for them as a continuing part of the lunar
bio-characterization program at MSC. The nature or actual
cause of the glomerulonephritis, however, is.unknown. It is
most probably caused by viral agents within the basement
membranes during the life of the animal and similar to the diseases
described by Oldstone and Dixon (2).
In this report the examination of a control group of
CD-I Charles Rivers 15 mo old mice are reported. Of the 57
mice examined 87% had indications of disease by immunofluorescence
techniques. .
METHODS AND MATERIALS
Tissues from the 57 control animals were obtained from
Dr. J. M. Holland, coordinator of the mammalian animal
quarantine protocol. Frozen sections of the kidneys were
examined for fluorescence following reaction with goat
anti-mouse gamma globulin. Selected positive tissues were
further examined for fluorescence with goat anti-mouse IgG,,
IgGp, IgA, and IgM. Exact procedures and photography methods
were previously described (i).
RESULTS
Tabulated results are shown in Tables 1 and 2. The
individual animals are grouped and are compared to those
animals examined and reported in Report 1 (l). The criteria
for each category are defined in a note to Table 1. Categories
I, II, and III of Report 1 correspond to categories 2, 3, and
4 respectively of the present report. The new categories
0, and 1 represent less severe disease states that were not
seen in the 17 mo CD-I animals described in Report 1. As
can be seen in Table 2, 56% of the animals were in very early
stages of glomerulonephritis (category 1). 31% were in
categories 2 and 3. No animals examined were in the final stages
of glomerulonephritis and subsequent total kidney failure (category 4)
The germ free males, germ free females, and conventional
males all yielded similar data. The conventional females (CF)
represented a divergent group with significantly more severe
stages of disease. 43% of the CF were in category 2
while the other three groups had 15-19% in the same category.
IgM only was found on the glomeruli as the bound immimo-
globulin.
TABLE 1
ou-p Animal
signation Numbers
mo Germ 045, 048, 050
ee Males
041, 042, 043, 044, 049,
051, 052, 062
046
047
None
' mo Germ 058, 059
•ee Females
061, 063, 064, 065, 066,
067, 068
060
053, 057
None
i mo 079
nventional
les 073, 074, 077, 078, 080,
Categories
0 1 2 3 4
3
8
1
1
0
2
7
1
2
0
1
081, 082, 083, 085, 086,
087, 088 .12
075, 084 2
076 1
None \ ] 0
mo 095 1
nventional
males 089, 097, 101, 102, 103 5
091, 092, 093, 094, 095
099, 104 7
090, 098, 100 3
None 0
Note to Table 1.
Category 0, no fluorescence
Category 1, any small degree of fluorescence in any glomerulous,
otherwise essentially normal appearance
Category 2, all glomeruli fluorescing, no enlargement noted
Category 3, all glomeruli fluorescing, 50% beginning to enlarge
but convolutions still intact
Category 4, all glomeruli fluorescing and enlarged, convolutions
and normal structure are missing.
TABLE 2
Group Designation Percentage (Actual No.) of Animals
in Categories.
Controls:
A. Present Study
1. Germ Free Females, 15 mo
2. Germ Free Males, 15 mo
3. Conventional Females
15 mo
4. Conventional Males
15 mo
B. Data from Report 1 .
Conventional Males &
Females
Injected:
Data from Report 1. for
Apollo 12 Lunar Material
Injections
0
17(2)
23(3.)
6(1)
6(1)
0
0
1
58(7)
62(8)
31(5)
75(12)
0
0
2
8(1)
8(1)
44(7)
13(2)
40(2)
0
3
17(2)
8(1)
19(3)
'6(1)
60(3)
50(2)
4
0
0
0
0
0
50(2)
DISCUSSION
The major conclusion that may be drawn from the present
data is that the degree of involvement in the 15 mo old
control animals of this study is not as advanced as that
seen in the 17 mo injected animals in the previous Report 1(1).
12% of the 15 mo controls show category 3 involvement, and
none were in category 4. 20 month old control animals will
be examined at a later date to determine their status.
The need for a more controlled disease state to study
how lunar materials may be interacting in the biological
system is becoming more pressing. The scope of a project
to define the glomerulonephritis seen in the CD-I Charles
Rivers mice would require more time, technical assistance, .
and equipment than is presently available. Oldstone and Dixon (2)
have only recently, after many years effort, succeeded in
describing glomerulonephritis due to IgG and virus attachment !
>
to the glomerular basement membranes. Only one other group
of investigators (3) have described IgM attachment as is seen
t
by us. These investigators are .still in the process of
describing the disease and causative agents.
By examining the effect of lunar and lunar simulated
materials in an induced controlled disease state, one could \
determine the stages in the biological processes that might
be involved and further determine if the lunar and simulated
lunar materials do indeed act the same. If indeed they do
act similarly then one could try various combinations of
individual elements from the similated materials to determine
which ones might be the most important in influencing biological
systems under stress from ensueing disease.
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APPENDIX
III. Progress Report No. 3: Effects of Lunar Material
on 5 month old CO-1 Mice
Progress Report No. 3
(January 24, 1972)
Effects of Lunar Material on 5 month old CD-I Mice
B. Sue Crisweil, Ph.D.
Postdoctoral Fellow
Department of Microbiology
Baylor College of Medicine
Houston, Texas 77025
ABSTRACT
Kidney tissues from two groups of mice were examined by
immunofluorescent techniques. One group of mice was 6 mo« old
and had been injected with either lunar material or terresterial
material 5 mo. previously. A second group of mice were 5 mo.
old and had received no prior injections. 60% of the 5 mo.
old animals already had bound immunoglobulin on their
glomeruli.
Introduction:
As a continuing part of the lunar bio-characterization program,
5 mo. old control and lunar inoculated animals were examined for
kidney lesions evidenced by immunofluorescence.
Methods & Materials:
Procedures have been given previously (Reports 1& 2).
Results & Discussion:
Tabulated results are shown in Tables 1 & 2. The individual
animals are grouped and results summarized in Table 3. The criteria
for each category was given previously in Report 2 (2). As can
be seen in Table 3, 60-63% of all 5 mo. old CD-I mice studied
were in the early stages of glomerulonephritis (Categories 1 & 2).
One animal was in more advanced stages (Category 3); however,
this animal (#125) did not possess the same type of kidney disease
as all the others. The predominant immunoglobulin on this kidney
was IgG with some IgM. On all other animals IgM with trace amounts
of IgA were found but no IgG. There appeared to be no significant
difference between the control animals and the injected ones indicating
that the lunar material or simulated lunar material seemed to have no
disease enhancing capacity. There was also no difference between
the lunar injected animals and the terresteria! group.
One significant difference did appear among the control animals.
Control conventional females displayed enhanced stages of disease
compared with the conventional males, germ free males, and germ
free females,
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TABLE 1
Group
Designation
Conventional
Males
5 mo. CD-I
Conventional
Females
5 mo. CD-I
Germ free
Males
5 mo. CD-I
"f
Germ free
Females
5 mo. CD-I
Animal Numbers
138, 139,
150, 152
137, 141,
146, 149,
148
None
None
None
153, 154,
163, 164,
155, 157,
167, 168
None
None
107, 109,
116, 117,
105, 106,
- 115
None
None
None
126, 128,
134
121, 122,
131, 135,
123
125
None
140, 144, 147,
142, 143, 145,
151
156, 159, 162,
165, 166
158, 160, 161,
111, 112, 113,
118, 119
108, 110, 114,
129, 132, 133,
124, 127, 130,
136
Catagories
0 1 2 3 4
7
8
1
o
0
0
9
• . . .
 7 : • - • ; -
0
0
9
'.-•6
0
0
0
6
8
1
1
0
TABLE 2
Group
Designation
Conventional
CD-I 5 mo.
Terr. Inj.
Males
Conventional
CD-I 5 mo.
Terr. Inj,
Females
Conventional
CD-I 5 mo.
Lunar Inj.
Males
Conventional
CD-I 5 mo.
Lunar Inj.
Females
Animal Numbers
001, 002, 003, 006, 009,
010
004, 005, 007, 008,
None
None
None
018, 019
012, 014, 015, 016, 017,
020
Oil, 013
None
None
021, 024, 025, 026, 027,
028
022, 023, 029, 030
None
None
None
034, 035
, 031, 032, 033, 036,
037, 038, 040
039
None
None
Catagories
0 1 2; 3 4
6
4
0
0
0
2
6
2
0
0
6
4
0
0 .
0
2
7
1
0
0
TABLE 3
Group
Designation
Percentage (Actual No.) of Animals in Categories
0 1 2 3 4
Controls:
1. Conventional Males
2. Conventional Females
3» Germ Free Males
4. Germ Free Females
44(7) 50(8) 6(1) 0 0
0 56(9) 44(7) 0 0
60(9) 40(6) 0 0 0
37(6) 50(8) 6(1) 6(1) 0
Injected:
Conventional Males -
Terresterial Material
Conventional Females -
Terresterial Material
Conventional Males
Lunar Material
Conventional Females -
Lunar Material
60(6) 40(4) 0 0
20(2) 60(6) 20(2) 0
60(6) 40;(4) 0 0
20(2) 70 (7) .10 (1) 0
0
0
0
0
Cumulative Totals:
.1. 5 mo., Controls
2. 5 mo. Injected Animals
35(22)49(31) 14(9) 2(1) 0
40(16) 53(21) 7(3) 0 0
APPENDIX
IV. Progress Report No. 4: Effects of Lunar Material
on 10 month old CD-I Mice
Progress Report No. 4
(March 6, 1972)
Effects of Lunar Material on 10 Month Old CD-I Mice
B. Sue Criswell, Ph.D.
Postdoctoral Fellow
Department of Microbiology
Baylor College of Medicine
Houston, Texas 77025
Abstract
Kidney tissues from 10 mo. old CD-I mice that were
either germ free or conventionally housed were examined by immuno-
fluorescent techniques. 72% of the 10 mo. old animals had bound
immunoglobulin on their glomeruli.
Introduction:
As a continuing part of the lunar bio-characterization program,
10 mo. old CD-I mice both germ free and conventional were examined
for kidney lesions evidenced by immunofluorescence.
Methods and Materials:
Procedures have been given previously (Reports 1&2).
Results and Discussion:
Tabulated results are shown in Tables 1 & 2. The criteria for
each category was given previously in Report 2 (2). As can be
seen in Table 2, 72% of all 5 mo. old CD-I mice studied were
in the early stages of glomerulonephritis (Categories 1 & 2). One
animal (#217) was in more advanced stages (Category 3). Staining
with Anti IgA, IgM, IgG^ and IgG2 showed that the predominant
immunoglobulin present was IgM; however, small amounts of the other
immunoglobulins were also detectable.
There appeared to be a significant difference between the
conventional females and the other groups. The germ free males
appeared least involved. Again, as seen previously, the females as
a group were in more advanced stages than the males.
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Table 1
Group
Designation
10 Mo. GF
MALES
10 Mo. GF
FEMALES
10 Mo.
CONV.
MALES
10 Mo.
CONV.
FEMALES
Animal Numbers
169, 171, 172, 173, 174, 175
176, 177, 178, 179, 181
170, 180, 182, 183
184
None
None
192, 197, 198, 200
185, 186, 187, 188, 191, 193,
194, 195, 196, 199
189, 190
None
None
210, 211, 212
201, 202, 203, 204, 205, 206,
207, 208, 209, 214, 216
213,215
None
None
None
219, 222, 223, 224, 225,
226, 227, 229, 232
218, 220, 221, 228, 230, 231
217
None
0
11
4
3
0
Ca
1-f
4
10
11
9
tegori
2+
1
2
2
6
es
3+
0
0
0
1
4+
0
0
0
0
Table 2
Group
Designation
Germ Free Males
Germ Free Females
Conventional Males
Conventional Females
Percentage (Actual
0 1
69(11)
25(4)
19(3)
0
25(4)
63(10)
69(11)
56(9)
No.) of Animals in Categories
2 3 4
6(1)
12(2)
12(2)
38(6)
0
0
0
6(1)
0
0
0
0
Cumulative Total 28(18) 53(34) 17(11) 2(1) 0
APPENDIX
V. Final Report: Comparison of Control 2, 5, 10, & 15
nxmth old CD-I Mice with Mice Receiving Lunar Materials:
Effects Upon a Chronic Autoircmune-Like Glomerulonephritis.
Final Report
(April 15, 1973)
Comparison of Control 2, 5, 10, and 15 Mo. Old
CD-I Mice with Mice Receiving Lunar Materials:
Effects Upon a Chronic Autoimmune-like Glomerulonephritis.
B. Sue Criswell, Ph.D.
Department of Microbiology & Immunology
Baylor College of Medicine
Houston, Texas 77025
Abstract
Of 23 CD-I 2 mo. old mice, 4 had evidence of immuno-
globulin on the surfaces of their kidneys, indicating a very early
beginning of an autoimmune-like disease in these animals. As the
animals aged, the kidneys became progressively effected.
Lunar materials or. terresterial simulated lunar materials
injected I.P. did not alter the chronic disease course.
2,
INTRODUCTION:
As a continuing part of the lunar biocharacterization program,
2 mo. old CD-I mice, both germ free and conventional, were examined
for kidney lesions evidenced by immunofluorescence. This report con-
cludes the control study for the biocharacterization program. CD-I mice
receiving either terresterial simulated lunar materials or lunar materials
and allowed to age to 10 months and 15 months, respectively, were
examined for their response to this chronic disease state.
METHODS AND MATERIALS:
Procedures have been given previously (Reports 1-4).
RESULTS:-! > ; ;
Tabulated results are shown in Table I for 2 mo. old CD-I mice.
The criteria for each category has been given previously in Report 2 (2).
In addition the categories have been evaluated photometrically by use of
a Leitz MPV. Category 0 photometrically measured between 100-450 OD;
Category 1 = 400 - 600; Category 2 = 500 - 1000; Category 3 =
1000 - 2500; Category 4 = 2000 - 4500. The photometric readings
measured only intensity of fluorescence. The categories were established
to include other perimeters. Therefore, overlapping of numerical values
occurred.
Additional control studies were done to show the specificity
of the immunoglobulins used. The antisera were tested electro-
phoretically to determine purity and were blocked with unlabelled
antisera [i.e., anti-IgM unlabelled blocked Anti-IgM (fluorescein
tagged) from binding to the glomerulous]. All antisera used were
established pure by both methods.
Results of injecting 2 mo. old mice with either lunar or
terresterial simulated lunar materials and then examination at 10,
and 15 mo. of age are shown in Tables II and III. In Table II,
males at 10 mo. injected with lunar material had more advanced
disease than males injected with terresterial material. On the other
hand, females with lunar material evidenced less disease than females
with terresteriai materials. Upon comparison with control animals in
Table IV no statistical differences were observed. Too few germ free
females survived until 15 mo. to analyze. However, the males at
15 mo. (Table III) did not differ regardless of what they had received.
DISCUSSION:
The previous three studies and this one point to the fact that
the CD-I strain of mice develop normally an accumulation of immuno-
globulin on their glomeruli basement membranes resembling the disease
of the NZB or B'/W hybrid mice (Burnet, 1972). The actual etiology
of this condition remains a subject of extensive debate. The females
appear to be affected sooner than the males.during the course of their
lives. The germ free animals are slower to contract the disease
than the conventionally housed animals.
Those animals that received lunar materials did not differ from
those animals receiving terresterial simulated lunar material in seventy
of the disease. The injected animals tended to fall lower than the
non-injected controls at 5 mo. of age. However, by 10 mo. all
groups appeared equal in distribution of the disease. The injected
materials appeared to have little lasting effects upon the course of
this naturally occurring chronic disease state.
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Table I
Group Categories
Designation Animal Numbers 0 1+ 2+ 3+ 4+
Germfree 313, 314, 315, 316,
2 mo. Males 317, 318, 320 7
319 1
Germfree 322, 323, 324, 327,
2 mo. Females 332, 333, 334, 335 8
336 1
Conventional 382,383,385 3
2 mo. Males .,04 -i
Conventional 338 1
2 mo. Females ~~-, _ .
Table II
Apollo 15 - 10 mo. CD-I
Lunar Injected:
Males, 10 mo.
(Conventional)
0 1+ 2+ 3+ 4+
233, 239, 240
234, 235, 236
237, 238, 241
242
(3)30%
•' -- -.' (6)60%
(1)10%
0 0
Females, 10 mo.
(Conventional)
252
244, 246, 247,
248, 250
251
(1)12.5%
(6)75%
(1)12.5%
0 0
Terr. Injected-'
Males, 10 mo.
(Conventional)
254, 255, 257,
258, 260, 261,
262
253, 256, 259
(7)70%
(3)30%
0 0 0
Females, 10 mo.
(conventional)
270
263, 265, 268,
269
264, 267, 272
266, 271
(1)10%
(4)40%
(3)30%
(2)20%
0
Table III
Apollo 15 - 15 mo. CD-I
Lunar Injected:
Males, 15 mo.
(Germ free)
Females, 10 mo.
(Germ free)
Terr. Injected:
Males, 15 mo.
.(Germ free)
Females, 15 mo.
(Germ free)
0 . 1+' 2+
386 (1)12.5%
382, 383, 384,
387 (4)50%
385, 388 (2)25%
389
None
394 (1)17%
393, 395 (2)33%
390, 392 (2)33%
391
None
396 (1)17%
398, 400, 401 (3)50%
397, 399 (2)33%
None
None
None (0)
402 (1)100%
None (0)
None
None
3+ 4+
(1)12.5%
(0)
(1)17%
(0)
(0)
(0)
(0)
(0)
Table IV
Summary Table of Comparative Data
oup
tsignation
mtrois:
, -2 mo. Conv. Males
2 mo. Conv., Females
'-£ mo. Germfree Males
2 mo. Germ free Females
. :*5 mo. Conv. Males
£> mo. Conv. Females
Vf5 mo. Germ free Males
s5 mo. Germfree Females
. 'XO mo. Conv. Males
"10 mo. Conv. Females
10 mo. Germfree Males
.10 mo. Germfree Females
. :15 mo. Convo Males
.15 mo. Conv. Females
JL5 mo. Germfree Males
«15 mo. Germfree Females
ijected :
. 5 mo. Conv. Males: Terresterial Mat.
"5 mo. Conv. Females: Terr. Material
15 mo. Conv. Males.- Lunar Material
5 mo. Conv. Females: Lunar Material
. 10 mo. Conv. Males: Terr. Material
10 mo. Conv. Females: Terr. Material
10 mo. Conv. Males: Lunar Material
10 mo. Conv. Females: Lunar Material
. 15 mo. Conv. Males: Terr. Material
15 mo. Conv. Females: Terr. Material
'15 mo. Conv. Males: Lunar Material
.15 mo. Conv. Females: Lunar Material
Percentage (Actual No.) of Animal
0 1 2 3
66(3)
50(1)
88(7)
89(8)
44(7)
0
60(9)
31(5)
19(3)
0
69(11)
25(4)
6(1)
6(1)
23(3)
17(2)
60(6)
20(2)
60(6)
20(2)
70(7)
10(1)
30(3)
13(1)
17(1)
0
13(1)
17(1)
33(1) 0
50(1) 0
12(1) 0
11(1) 0
50(8) 6(1)
56(9) 44(7)
40(6) 0
56(9) 6(1)
69(11) 12(2)
56(9) 38(6)
25(4) 6(1)
63(10) 12(2)
75(12) 13(2)
31(5) 44(7)
62(8) 8(1)
58(7) 8(1)
40(4) 0
60(6) 20(2)
40(4) 0
70(7) 10(1)
30(3) 0
40(4) 30(3)
60(6) 10(1)
75(6) 13(1)
50(3) 33(2)
100(1) 0
50(4) 25(2)
33(2) 33(2)
0
0
' 0
o
0
0
0
6(1)
0
6(1)
0
0
6(1)
19(3)
8(1)
17(2)
0
0 .
0
0
0
20(2)
0
0
0
0
13(1)
17(1)
s in Categories
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Table IV (continued)
0
lumula t ive Totals:
.. 5 mo. Controls
5 mo, Terresterial Material
5 mo. Lunar Injected
!. 10 mo. Controls
10 mo. Terresterial Injected
10 mo. Lunar Injected
». 15 mo. Controls
15 mo. Terresterial Injected
15 mo. Lunar Injected
33(21)
40(8)
40(8)
28(18)
40(8)
.22(4)
12(7)
.14(1).
14(2)
51(32)
50(10)
55(11)
53(34)
35(7)
67(12).
56(32)
57(4)
43(6)
14(9)
10(2)
5(1)
17(11)
15(3)
11(2)
19(11)
29(2)
29(4)
16(1)
0
0
2(1)
10(2)
o
12(7)
0
14(2) .
0
0
0
0
0
0
0
0
0
APPENDIX
VI. Methods and Materials
LYMPHOCYTE SEPARATION
using Techincon Separator
If lymphocytes are to be cultured later, the blood sample should
be collected in a sterile, heparinized tube and all supplies used here-
after in the separation must be sterile.
If lymphocytes are not to be cultured, non-sterile supplies can .
be used. •
1. Remove separating reagent from refrigerator and place in a 37 C
incubator or H_0 bath for approx. 1 hr. or allow to sit at room temp,
for 2 hrs.
2. Collect blood in a 15 ml. vacutainer tube containing 3 mis. Na Heparin.
Make these tubes up in advance to keep on hand. If another size
vacutainer is used, use, 4 ml. Ha Heparin/20 ml. blood.'
3- Type the blood with ABO typing serum.
4. If more than 5 mis. of blood are collected, the sample may be. spun down
at setting 3/4 on ICC centrifuge for 15-20 mins. Take off most of the
serum and save. Remove the buffy coat generously, taking some RBC's
and the remaining serum that was left and place in a vial.
5- Take separating reagent and shake well to mix the iron filings. Using
a 5^cc. B-D syringe and a 20g. needle, withdraw reagent in the amount
of kx the volume of blood.
Ex.: For 5 mis. of blood, use 20 mis. reagent.
6. Withdraw into the syringe approx. 1 ml. of typing antisera according
to the person's blood type.
7- If the buffy coat is being used, mix it well with a pasteur pipette.
Draw the blood into the syringe containing the reagent and antisera.
8. Draw an airspace into syringe equal to the volume of the mixture and
cap the needle with 'a vinyl cap.
9- Mix by inverting several times.
10. Place the syringe on Technicon rotator which is kept in a 37 C incubator.
Allow to rotate for 3° mins.
11. Remove syringe from rotator, remove the airspace and tap out any air
bubbles present, and replace the needle with a clean one.
12. Allow syringe to sit in the rack (also in incubator) for 30 mins.
13. Take the sample through the Technicon Separator. If the sample is to
be kept sterile, wipe-the tubing and the top of the collection tube
and its holder with alcohol and allow to dry before inserting needles.
Ik. Spin the collected sample in the tube for 10 mins. at speed 3/4 on
ICC centrifuge.
Technicon Separator (con'd) • ' • • '
15. Remove the supernatant and discard. " .
16. .Using a long pasteur;pipette. extract the pellet, rinsing with MEM,
into a fisher tube. . • '
17- Spin at 2500g for 2 mins. or 1500g. for 3 rains. Remove Supernatant.
IS. Rinse pellet 2X with MEM as above and place in 1 ml. MEM.
19- Mix well and count on Hemacytometer. Count the 5 small squares.
20 If the sample has too many REC's to count, use diluting pipette. Count
the V large squares.
LYMPHOCYTE CULTURE TECHNIQUE
Blood Collection.
1. 10-20 ml. blood is cravm and placed into & :,0 nil. sterile erhlenmeyer
flask containing sterile acid washed glass beads (3 beads/1 ml. blood;
beads are 3^ -'r! i^- diameter) .
2. Swirl flask for 10-15 min. until beads can no longer be heard rattling
in flask (but do not swirl so hard as to induce frothing of blood) .
1. In sterile culture tubes add 1 part Sterile (autoclaved) h-% dextran
in saline for every 9 parts of blood.
2, Transfer the defibrinated blood to the dextran culture tubes filling
to approximately 1/2 volume and invert several times to mix.
3- Place tubes on a 10-20 slant for tj? min. for females and oO min. for
males. The blood should reach the top of the tube when slanted, and
there should be an air-blood interface at the bottom of the tube..
4.- After allowing to sit, stand the tubes upright (very gently) and
wait about 5 min.
5- Remove plasma -from ssjaple with sterile pasteur pipette.
A. Do cell count on hemacytometer by diluting in WBC pipette with •
2^> Acetic Acid sol'n. (Count the V-large WBC squares and • •
multiply the number by 5,0 X 104 to get number of cells/ml.)
B. Bo a differential on same • hemacytoinater prep, counting 100 WBCs.
6. Spin the RBC's that are remaining at 2000 rpm to recover as- much
plasma as possible. .
' 6
7. According to counts, dilute the leukocyte suspension to 1 X 10
lymphocytes/ml. Use patients own serum obtained from flo.6 as the
diluent. (Can use .5 X 10° lymphocytes/ml, and not change the results
significantly)
Cult-ore Technique
1. In a sterile 15 X 12Jir.ni culture tube add 2cc of I-EM Media-Spinner
Modified to which Pen-Strep (ice/IOC ml. M5M) and •."lutamine
(Ice/500 ml. MEM) have been added. \- ;. .•.••"."•••. ' •'" ' '
- <• . . ' • ' • ' ;
2. Add Ice. of lymphocyte suspension to each culture tube.
3. Add antigens to culture tubes last. Keep one control tube.
Antigens: A. Stre-otolysin G: 0.1 :nl./culture
B. ?clkv/eed Nito^en: 0.05 rcl./culture
C, KLH: 0.1 ml./culture .
(Keyhole Limpet Hemocynanin)
Three concentrations mads and used: 3 mg/ml, 0.3 mg/ml,
and 0.03 ng/ml (0.3 mg/ml gives best results)
Di Veridas.e: 0.1 nil/culture
MeJ<ie up so have 0.6 - 1.3 rag/.l ml.
(Make up according to Streptocynase which is'20,000 units.
Add 2cc Had making it 2,000 units. Dialize .for 2 days
against saline to remove preservatives. Then millipore
and store in sterile containers. Order a large amount
with the same lot number and store. Run-a protein deter-
mination also.)
E'. Con A: . . .
F. Paytohemagglutinin M-Bacto: 0.05 ml/culture
Add this antigen last. '• ' .
k. Mix tubes on vortex mixer (slowly). .
 :
5.. Loosen caps and put into humidified incubator that has 5'2» COo (Hersh
gauge set at 0.2) and 10% Air (Hersh gauge set at k and f^O in line
taken out with Pram-Oil Filter). C02 tank was 100% C02 - Liquified
USP grade.
6. Incubate PKA cultures for 3 days; all others go for 5 days for ENA
analysis.
H-Thyraidine Uptake Procedure
1. Isolate lymphocytes.-
2. To 10 lymphocytes add l^c in O.lcc of H-Thymidine to each
sample (culture). "H-Thymidine has been diluted with sterile water
to 1.9 curies/milliiaole.
3- Incubate for 2 to 3 hours at 37°C.
k. Place in ice bath to chill 10-15 mins. Maintain everything cold
from this point on.
5. Centrifuge (refrigerated centrifuge) at 1500-2000 for 10 mins.
Discard supern.
6. Add kcc cold saline, vortex, and centrifuge as above. Discard
supern., (Can freeze samples here to save)
7. Add 4cc 5^ TCA after thawing. Place on ice for 15 mins. and
centrifuge. Discard supernatent. . • ' ,
8. Add kcc y/o TCA again, vortex, and place on ice for 10 mins.
Centrifuge and discard supern. (The button will be.pinkish brown.)
9- Add kcc methanol - to decolorize RBCs - vortex, and centrifuge, -
Discard supernatent. (Hay have to repeat for more decolorizing
to reduce quenching.)
10. To the button add 0.5cc Soluene and vortex to resuspend.
11. Place in 60 water bath for 30 mins. (Can refrigerate now and
store overnight) '
12. Add 10 ml of scintillation fluid. (To transfer, the ppt from the
testtube to the counting vial, add only 5 nil of scin.. fluid,
transfer this to the counting vial, and then add the other 5 ml ,
to the testtube to wash out any remaining ppt and add this to the
counting vial.)
13- Cover samples for 30 mins. in the dark before counting.
l4. Count for 50 inins. (Run blank of 0.5 ml soluene and scin, fluid.)
r.tjUj/.fcnt Supply Sciu-cc-s: For lyiapnccyte c'olturin^; technique
I. :;extrari, (grade HH, pyrc^n free.-, 2 i'r. . Ave. M.W. ^-i-0,000}
p--;armache:fi Corp . . . . .
?.'. Pinic illin-Streptoi.-vycir: :-;ol'n (10,000 unitr. Pon i '.• 1 .1 J in plus
10,000 meg Ctr^ptomyoln/rl) Unit iMss: 20 ::u. . at P.'tiO each Bottle
! ; nt . No . 5 1'-
r: loco
^,. Pokew-red Mitogen Unit size: 5ml. at 5.|jO each bottle . .
(Shipped on ice)
Cat. Eo. 536
Gib co
i*-. -L-niutamine (GOOsuM) (100X) , 29.2 isg/ml, Unit Size: 20 ml. at
3.50 each bottle
Cat. No. 503 '• . •
(Shipped on ice)
Cibco .
5. S-i^EJ-1 Minimum Essential Media (Eagle) (IX) . •
vith Earl's salts (Spinner raccified)
v/ithout L-Glutamine
Unit size: 100 ml. at 2.30 each bottle . Cat. No. 13#
Gibco
"j .
6. Bacto Strepto'lysin 0 Reagent
6 bottles of 10 ml each for 7.50 .
Cat. No. 0^ 82-60-4 . '
Dif co - •
7. Phytohemagglutinin ?/:-Bacto, .
6 bottles of 5 ml each for 21.25
Cat. No. 0528-57 -5
Difco • . N
b. KLH (Keyhole Limpet riem
f]ven iEiavinosxrppressed can be stimulated with this. Divers may become
immune to this. Associated fern used MW - l6o,000
Three concentrations made and used (See Procedure)
Procedure for making up in Irrjaunolo;r/ by Carrpbell (uses live linrpets)
Pacific Bio. ?-1arine Hurpl.y
Box 536 Denies, CalifV' Order FOB Los Angeles
(They may have prepared KLH also)
9. Veridase (for intervenous injection)
Make up according to 3l.reptocyr.ase which is SO, 000 units
Add: 2cc KaCl roaking it 2,000 units. Bialize for 2 days against saline
to remove preservatives. Then aillipore and store in sterile containers.
Order a bunch with same lot no. and store. Rim a protein determination
also. Use .Iml/culture of .6-1.3 nig/.l ml
p^ckarc pr.;ouots
A^c tolur.e siov/Iji to 1 liter
LYMPHOCYTE SEPARATION .
" Ficol Method -
. . . . . . .(Dr. Hersh's Lab)
Coat all glassware with Siliclad to prevent lymphocytes from
sticking. . . . '
Preparation of Reagents:
1. Ficoll: 100 grains to 1100 cc. d.HpO (Makes 9^sol'n)
Autoclave 15 mins. on liquid cycle to dissolve and
sterilize. Keep refrigerated. ' • .
2. Hypaic: Dissolve 50 mis. in 83 mis. sterile HO, rinsing
bottle thoroughly. (Makes a 33.29<j£sol'n.) ..
Keep refrigerated. . •
3. Tris-Buffer (for.removing RBC's from prep.):
a. 4.1188 grains Tris Trizma base dissolved in 200 ml.
. .
 d
-
H
2° '
 :
 '
b. pH to 7.65 with HC1
c. 14.94 grams KH.C1 dissolved in l8oo ml. d.H 0
. d. Add Tris
e. pH to 7.2 with HC1 • .
f. before using warm it to 37 C.
',) • •
PROCEDURE; ' ta#&-;
—' " . -A / h**" . . .
1. Defibrinate blood and dilute 3:1 with sterile saline •
2. Layer blood over ficol (approx. 3 part blood to ? parts ficol,
or as to give blood a good distance to travel down to bottom of
tube) ' . .
3-'. Centrifuge at 500 g or 1500 rpm (check chart for Fisher centrifuge)
for 40 min. or 2500 for 15 min.(gives more .RBC contamination on
higher speed and shorter, time)
4. With pipette, combine Lymphocyte layers (filling tubes 1/2 full)
Usually get 90^lymphocytes and 1Q0/, monocytes and polymorphs
5. Fill tube containing lymphocytes with Tris, mix, and let sit
for 10 mins. (if need to remove RBC's) Spin .at 1000 for 10 mins.
to get pellet. Tris again if RBC's are still present
6. Rinse cells about 2X with media to remove Tris and Ficol.
Picol Separation (con'd.)
7- If do not Tris, dilute the lymphocytes 1 part cell suspension
to 1 part MEM so that when spun to get button cells will all
spin down and the gradient will no longer be present.
8. Add 1 mi. cells (l X 10 ) to 2 mis. MEM -
After culturing should have no less than 96^ viability.
Ficol - Hypaic Solution ;. (Make fresh each day) . . .
1 cc. Hypaic to 2.14- cc. Ficol
HW-28-J
Brand of
SODIUM AND MEGLUMINi D1ATR1ZOATES
Sterile Aqueous Injection 90% {weight/volume)
A Radiopaque Medium for Angiocardiography,
Aortography, Angiography, Urography,
and Hysterosalpingography
DESCRIPTION
Hypaque-M, 90 per cent i» a sterile aqueous solution containing 30 per cent
(weight/volume) of the sodium salt and 60 per cent (weight/volume) of the meglumine
salt of 3/5-diacelamido-2,4,o'-lniodobenzolc acid. Each ml. contains approximately
462 mg. of organically-bound iodine and 0.47 meq. (or 10.9 mg.) sodium per ml. The
solution is hypertonic ond hoj a viscosity of approximately 18.7 cps at 37°C. The pH h
adjusted with NaOH or HCI. Calcium disodium edetate 1i10,000 has been added as a
sequestering stabilizing agent. The solution may be auloclaved. It should be protected
from strong light. At body temperature the solution is clear and colorless to pale ilraw
color. Crystals may form in the solution on cooling; they are readily red'usolved on
warming; the solution, however, should b« administered at body temperature.
INDICATIONS, General
A rodiopoqua medium for angiocardiography, cartography, angiography, orography,
and hysterosalpingography.
CONTRAINDICATIONS, Genera!
Do not use Hypaque-M, 90 per cent for myelography. Injection of even a small
amount into the subarachnoid spcca may produce convulsions and result in fatality.
Hypaque-M, 90 per cent should not be injected directly into the carotid or vertebral
arteries.
WARNINGS, General /. .
Do not use Hypaque sodium for myelography. Injection of even a small amount into
the subarachnoid space may produce convulsions and result in fatality. Epidural place-
ment is not advised.
Intravascular administration of contrast media may promote :ickling in patients who
are homozygous for sickle cell disease.
Administration of radiopaque materials in patients inown or suspected to have
pheochrornocytoma should be performed with extreme caution. If, in the opinion of the
physician, the possible benefits of such procedures outweigh the considered risks, the
amount of radiopaque medium injected should be kept to an absolute minimum. The
Copyright, 197], Winthrop Laboratories
Suggested Hersh Value:;:
I. 0 Hour in Vivo st imulation - .("'??••;
'•$00 - 1,000 for n.-nr'jactlve or. ur^ti::;uiated
Above 1,000 for react 'I vi
.:-. PHA ran/^s - TilA-72- hr:;. - CFK
A.. Uti7.iu3.atcd; ;-;an.'-/=: I;";, 000 - 100.000 (r;>,000 considered extreme low)
Ave: 30,000 - ^ 0.000 '
B. tJnst ir:';uated . . •
Controls: Jeanne: 400 - 600
To Convert CPM to DPJ-i:
DPM = CF-!
efficiency1.
(using stds.) :
• 6
Kathy's calculations correcting CPM's to 1 X 10 viable cells is:
Total Count, _
 BackgroMnd CPM x 100
',- Time
DPM/1 X 10° viable cells —
No. of cells counted X 10 X % Viability
DPM/1 X 10 viable cells - CFM/1 x
Efficiency
AMMONIUM CHLORIDE RECIPE FOR REMOVING RBC'S
1. .Prepare Tris Buffer:
20.59U grams of Tris Base/liter d.h^O. Adjust to pK 7.65 with
IN HCL. ..
2. Prepare Ammonium Chloride Spl'n; 0.83 %
0.?3 gr.ams ammonium chloride/100 cc. d.rL^O.
3. Prepare a mixture of the above two solutions:
A. Add 1 volume of Tris Buffer to 9 volumes of .83% aqueous NHIjC&.
B. Adjust mixture to pH 7.2 with 1 N HCL.
C. For Sterile Work: Millipore filter with .22 filters. Store
at room temp, in small quantities. • '
To Use: . :
. 1. If not too many RBC's in pellet, add to top of tube (NKCl)
2. Resuspend
3. Let sit 5 mins.
^. Spin at 1,000 per min. to settle lymphocytes and leave debris
behind.
Reference; Boyle, W.., Transplantation, vol. 6, p. 761, 1968.
Counting ft W3C ' s UGin,—diluting pipette:
rf cell.-5 counted
in 4 wBC sauarfeu
vfhc ' s/ml. of san-.ple
T*T -*$+• — "
: I 1
•v
- a - .
,i
"ir~l!
Tr~
ffS r
iTTTf •
^TF-
i—f—tr
t
Formula for coimtlng cell cultures (without using_W3C diluting pipette):
ives total ^  of cells present in sample
• //'• cells counted X volume cells are in
.1 X •£: large squares counted
cells In
culture
:
'r,-pan Blue Stain: (0.'-,;.') in normal saline or order from GIBCO
•^'i.7•.'••/100 cc. (^ 10.00 - rdnitnum order)
Tris - Buffer: Trizrea H&se Reagent grade No. T-.lj03
___ — ^ Kiio^rajn molecular -equiv. ^ . 121.1
Doxtran, (grade -H, rYro^en free, P Ib .
'-?% :-:Ac for c-.-II cc^ ':t.-'?.
Mr.'M Mtdia - Spinner :A..nL£'ied
P^n-Strep
.V.'. 1^ 0,000)
Sterile distilled H0 (small bottles)
Metaanol
toluene
Toluene (Scint. grade)
'
::-Th;/7nidine (1.9 curies/ViiiliKiole)
Streptolysin 0
FMA-M
Con A
"ericiase
• A
KLH (Keyhole Lictpet Hernooyanin)
MEM Eag!«, Earie'a Baa«, Dahydraied, is a npnsterite
powder coDtaifling ait Of 5he Ingrsdtents of the McM
Eagie, Sard's baaa formula InctwJifig glutamine, but
without sodium bicarbonate.
Prepare a working aolulion by adding the powder from
ona or mora contairwr* to an appropriate amount of
dsioniied watar. Stir at room temperature until thor-
oughly dissolved {15 to 20 minutes). Sieriiiza by Mira-
tion through an appropriate bacteriological filter.
FinaiSy, add 23.4 ml. ol 7.5% Scdiuro Bicarbonata Soli»-
tion.paf Htar of medium.
M3NHMUM ESSEMTIAL MEDIUM- EAGLE,
1 CO fai. Ho.51 064
SCO Biifte. 51036
rr,g
rng
rrsg
mg
/-Arginine HCI ................ . ..... . . 126.98
/-Cyatina ....................... ..... 24
/-Giutamina .......................... 292
/-Hi3tidir.» HCI • HjO ................. 41.&3
/-Lsucina ............................ 52
,'-!5Oiaucin« ............. .... ......... 52
/-Lysine HCI ..... . .......... .... ...... 53
/-Maihionina .... ................. • ---- 15
32
48
KTryptophan ................. . ....... 10
/-Tyrosine ......... . ................. 39
/-Vaiir.e ............................. 48
Choiine Chlorida
Slot !n
relic Acid
Ca-O-?antoth»nat»
Fyritioxal HCI ........ .......... .' ..... 1
Thiamine HC!
Nicotinamids
Ri'Doflavin
Sodium Chloride
Potassium Chloride
Magnesium Suiiatd
Oaxtrcss
Monosodiurn Phosphata • H^O
Phenoi Red
Sodium B:carbonai» .
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
mg
g
g
0.118 g
1 g
1.33 g
0.005 g
2 g
1
1
0.1
6.3
0.4
LYMPHOCYTE SEPARATION 3Y HAND METHOD . ' -
1. Type the blood sample.- Pour it into a graduated centrifube tube and
add 2 ml. 5 '',PV?/10 ml. blood.
-2. Mix by inverting tube 5X.
3- "Centrifuge on setting 3/U on ICC centrifuge for 10 rnins.
-^ . Save 1 fisher tube of serui.i for later.
5. Remove buffy coat and put in fisher tube. . . • '.
6. Centrifuge at 2500g for 2 mins.
7- Remove buffy coat and place into cup (take some of the serum with it).
and add antisera in equal volume. . . -
Place on shaker under a light source for 5 mins.
Let stand for 5 mins. •
Place liquid from cup in a fisher tube, leaving afflutinated RBC's behind.
Do a "quickie" spin on fisher tube to remove any RBC's. .
•"Place supernatant in a clean tube and spin at 250~g for 2 mins.
"Resuspend the .pellet in a 1:1 solution of patient's serum and Hanks.
Place on straw column.
Incubate at 37 C in waterbath for 10 mins.
Flush straw with McCoy's medium into approx. '2-k- fisher tubes.
Spin tubes at 25^ 0g for 2 mins.
Resuspend pellets (combining them in one tube) in. .1 ml. McCoy's.
"'Count on Hemacytometer. Use 5 small squares.
Preparing Phosphate Buffered Saline Solution (FB3) : ?H
Stock A: NaHgPOi; • HpO t6gm/lLiter
92gm/2 Liters
Stock B: WagHPOj, t7.3ga/l Liter
9^.6gm/2 Liters
For 6.Liters PBS:
Had 52.26 gas.
Stock (A) 9.6 cc.
Stock (B) 50.^ cc.
To 6 Liters with d . H °
For 8 Liters PBS;
Wad 69.68 gms.
Stock (A) 12.8 cc.
Stock (B) ' 67.2 cc.
ACRIDIWE ORAIJ'E STAH'IUF PROCEDURE FOR
LYMPHOCYTE CYTOFLURO'"RAPH STUDIES
•'1. Separate lymphocytes by standard procedure using Technicon Separator
and count.
2. Centrifuge, withdraw supernatant and resuspend cells in 2 ml.
buffered formalin (cold) *
3- Refrigerate for 3-5 hours (note the exact time)
t. Add cells (still suspended in formalin) into Cold Acridine Orange
•at 0.5 X 10° cells/2 ml. stain, store in refrigerator in a dark ' '
stoppered vessel. Record tine cells added to stain.
7
' The. amount of formalin needed is arbitrary depending on the number
of cells stained.
FLUORESCENT ANTIBODY STABIBr OF LYMPHOCYTES
Calculating Results
Cytoflurograph: On 2-8 window readings - add M, r', and A and see if they
equal T. Calculate what Vo of T it is. .
Fl. Microscope: Calculate ^ fluorescence ( from scope readings by putting
the number of flucrescing lymphocytes over the total number
of lymphocytes counted ) on T, M, r, and A samples. Add
M, 0, and A to see if they equal T. Calculate what % of
T it is.
Viability: Get a ^ viability and %lymphocytes in each prep, from the
hemacytometer readings.
Take the cytoflurograph readings (%) for T, ^,-M, and A, and using
'the % of lymphocytes in the differential, calculate the ^ fluorescence on
the cytoflurograph.
Cytoflurograph __ ^ fluorescence
Lymphocytes
Add M, n, and A to see if equal T. Compare to /0 found from microscope.
FLUORESCENT ANTIBODY STAINING OF LYT'IPHOCYTBS
for ?1. Microscopy and cytoflurograph
-* .
1. Spin down samples, in Fisher tubes at 2pOO rpm for 2 mins.
(or 2000 e, for 3 mins.)
2. Wash each sample with cold PBS X 3-
'3- On third wash divide each sample into 5 parts (.2 ml each: marked
unstained,'Total anti Ig, anti IgM, anti Igr, and anti IgA)
^. Spin samples down and withdraw supernatant
5. In each subsaraple add 2-3 drops of appropriate stain to pellet
and mix thoroughly, but gently. Do not make bubbles. Use 1:8 dilution
of stains.
6. Place samples in refrigerator for 30 mins.
7. Top each tube with cold PBS and mix. (This is wash-1}
••'..8. Spin cells at 2500 rpm for 2 rains. Wash X 2 with cold PBS . .
9- .Then add 1 ml. PBS to samples and mix.
10. Prepare 1 tube with 9 mis. cold PBS and k tubes with k mis. cold
PBS each to use in next step. Label as in step 3.
11. . When placing 1 nil lymphocyte stained samples in tubes prepared in
step 10, be sure to leave a few drops in bottom of fisher tubes to
use later.
Place 1 ml. of unstained into 9 mis. cold PBS
Place 1 ml. of Total into ^  nils.' cold PBS
Place 1 ml. of IgM into k mis. cold PBS
Place 1 ml. of Igr into h mis. cold PBS
Place 1 ml. of IgA into k mis. cold PBS
Mix well. Samples are now ready to be read on cytoflurograph.
1.2. Using the remainder of lymphocyte sample in bottom of fisher tubes,
take a drop and place it on a glass slide (slides used for fl.
microscopy) and coverslip with a 1 1/2 coverslip. Seal with
clear nailpolish. Store slides in a dark, cool place (refrig.)
until they are read.
Take another drop and adding trypan blue, mix together and place
on a hemacytometer. Do a viability reading and also a differential.
"* Use lymphocytes that have been separated with Technicon Separator,
preferably fresh, but can be used up to 2k hrs. old.
LYMPHOCYTE CULTUHHF" TECHNIQUE
All sterile supplies must be used.
1. .Label culture tubes as to the sample number ana the antigen to be used.
:2. .Dilute the lymphocyte sample to 1.0 X 10° cells/ml, with person's oT.-/n
serum or Fetal calf serum which has been inactivated previously at
56°C for 30 rains.
3- "Into each culture tube place 2 ml. of MEM to which pen-strep and
g.lutamine have been added.
^. Mix the lymphocyte sample.well and add 1 ml. of the sample to the
culture tubes, making a total of 3 mis. (33 ''"'• is serum).
5- Add antigens.
• -•&. Mix well and loosen caps.
.".?-• Place in an incubator at 37 C (see Dextran separation technique). Allow
cultures to go 3 days for ?HA and 5 days for Pokeweed Mitogen. (They
may go a few days longer if necessary, for convenience) . ' •
:
'8. Harvest (can now use non-sterile supplies) by removing the supernatant
(the cells will be at bottom of tube) and add 3 ml. fresh MEM. • •
Do a viability count with trypan blue if necessary.
'Lymphocytes are now read;
test is to be preformed.
.10. ." y for H-thymidine procedure or whatever other
LYMPHOCYTE SEPARATION PROCEDURE ( For the Mouse)
1. Collect k-5 nils, total heparinised blood by heart punctures
(will need 7-10 mice).
2. Centrifuge blood in an International Clinical Centrifuge at
.3A full speed for 10 mins. (a little longer if necessary to
make a good buffy coat layer)
3. Generous!;/ transfer buffy coat to a Fisher Centrifuge Tube,
mix, and centrifuge at 2500g. for 2 mins. in a Fisher Model
59 centrifuge.
^. Transfer buffy coat (with minimal red cells) to a 5 ml. cup
containing an equal vol. of anti-mouse serum which has been
diluted 1:2 (in PBS). Mix well.
5. Place cup on shaker under a light for 5 mins. • (may take longer)
and then allow to stand another 5 mins. or so.
6. Remove agglutinated red cells by low speed centrifugation
(Fisher model 59) at lOOOg. for 5 sees.
7. Centrifuge supernatant at 2500g. for 2 mins. (Will settle
all cells but the platelets.)
8. Resuspend cells in 1 ml. of s. 1:1 mixture of mouse serum
(saved from sample of blood) and Hanks BSS.
9. Optional: Quick spin (lOOOg. for 5 sees.) to remove remaining
RBC's, if present.
10. Place suspension on a if--inch column of coated glass beads.
.11. Stopper the straw at the lower end and incubate in a 37°C
water bath for 10 mins.
12. Flush lymphocytes into several Fisher tubes with McCoy's 5a
Medium, modified with 30% fetal calf serum.
13. Centrifuge tubes at 2500g. for 2. mins. to settle lymphocytes. .
IH-. Remove supernatants and combine all lymphocytes into 1 ml.
of McCoys. /•' • • ' • ' . . - / • • ' • • .-.: -•-' '
15. Mix veil and view under a hemacytometer.
16. Adjust count with McCoys to 1.0 X 10 lymphocytes/ml.
HEEDED FOR LYMPHOCYTE SEPARATION ATfD "H-THYMIDINE UPTAKE PROCEDURES:
Colunn-: • Coat glass beads by covering them with a 1% sol'n. of gum
arable and allowing them to dry thoroughly in a glass drying
oven. Break beads apart by grinding in a mortar and pestle
dish. Plug drinking straw'with glass wool and fill straw to
approx. 3" from top with the coated glass beads.
Working Stock o f ^H-t'nymidine; . . .
Original stock has 2 A.ci/100 (in 0.5 ml.)
Add 12.5 ml. sterile KpO to the original stock, rinsing stock
...vial with the water thoroughly into a clean larger vial^_...
squirt with a 100/1 pipette will give 2 microcuries.
Rabbit Anti-mouse Serum: •
Prepared by inoculating rabbit with pure mouse RBC's and
then using the rabbit serun (after it has been inactivated
at 56°C for 30 mins.) to agglutinate mouse RBC's.
Formulas for Calculating^- of cells/ml, using hemacytometer;
A -
(A) If Counting one large WBC square use:
ct. X vol.. - , 103X tconverts - cts-M-
.1 X large squares v -- ,
 nN0
 , j- nan TO ml)
counted
fcj ' •
(B) If counting RBC area, e.g. 5 small .squares in large
center square use:
ct
* . X vol. X 10 X 103 — cts./ml.
.2 (is .5 of
large square) •
(C) Above (B) vvritten differently: ' " '. •
Ct
'
 X VQl
- X 103
.1 X .2
Solutions
25 grans polyvinyl'oyrolidinone K-90
1 sterile 500 cc. bottle saline
Add ?Y? and roll gently; let stand overnight and mix gently
again .
Lechtin
1/2 cup seeds
Cover seeds with pK 7.2 PBS in blender. Blend until mashed.
Put in beaker 1 to 2 days. f .-i^ tiii .'£;s
Centrifuge ale precipitate
Test against an 0 cell
Store in freezer at -20*C.
Heparin
One bottle ITa Heparin
Add 100 ml., sterile saline
Store in refrigerator
Use .k ccs/20 ccs. blood
. ,. .... i
<»
"-EDURE FOR COLLECTION AMD FROCI'r.r.UJr. OF MOUSE KXUPATF.5
Prep mice by I.P. Ejection of 1.0 cc of j).l o/r. cXycort-n In nU-rlle r.nlinc.
(Keep refrigerated; discard when contaminated.)
Allow cells to inunigrate into the peritoneal cavity for '» tirr. Am-rtho-
tizc the mice with Met- -f anc and inject 5.0 cc .".t<:ri.lo ."..Til no P.P. with rv •
20G needle. Remove the syringe^ leaving the needle in pjace. CoJ?rct the
exudate into clean, dry, siliconized conical cent tube::.
Pellet the cells by centrifugation a 1500 rpm for 10 minute.-;. Pi::cnr<l
supernatant. .
Resuspend cells in tissue culture medium by gentle vortexln^.
After cells are completely reauspended, remove nliquots for tot'»i iVfPn, clirf,
and viability. ' . ;
Introduce cells suspended in medium into chamber: .^*^ — | ',"'.' ~-"i ~£~ v
C?.UA»H
Remove needles and place chamber in 37° water bath (held nbove wntor loyol
on platform) for 15 mixmtes. .
Remove chambers at 15 'minute intervals and observe ccllr. uring plii;--e micro-
scopy.
Record damaged cells, \vacuolated, rounded up, Pleating or obviou.-.ly viable
ceils that are well flattened, extended and showing evidence of movement.
Initially, we will be concerned with cell collection, preparation, and
preservation. The effects of such variables as time/aitcr preparation (bofore
collection), type of media, etc. will be evaluated.
Checking Fluorescent Antisera
. for
Fluorescent Specificity
(Fluorescent A.3. staining with Goat Antisera)
Remove liver and spleen from mouse: preferably mouse that has had some
disease (will have more antibodies)
Liver - used as control tissue
Spleen - where immunoglcbulins in mouse are produced
1. Take fluorescent antisera and thaw. Remove with syringe and place in
Fisher tubes. Label tubes.
2. Spin tubes at 5000g for 5 mins. to settle any ppt. present in antisera.
3- Remove serum ppt. and put serum in clean vials and relabel vials.
Check to see if vials are clean first.
^. Re-refrigerate vials and refreeze any you won't be using immediately.
Use Direct Staining Technique: Goat antisera undiluted gave highest
(k •*• fluorescence)
Direct Technique;
Mouse tissue:
Human cells:
FLUORESCENT STAINING
add fl. antisera - goat antisera against mouse
gamma globulin
add fl. antisera. to:
Human immune globulin G (igG)
Huinan immune globulin A (igA)
Human immune globulin M (igM)
all of these together
would be human gamma
globulin (whole)
(These bought commercially in pure form. Can test them
for purity with Immunoelectrophoresis.)
Indirect Technique;
(sandwich technique)
First apply antisera (unlabelled)
£
'
x
 - ' Take mouse blood smear (mouse..has a disease-
~i I
Add antisera (sera from a diseased mouse) and
incubate 30 mins.
Then add Fluorescent antisera against mouse
gamma globulin.and incubate 30 mins.
Immunoflourescence; Diagrahms
Direct Test: Defects antigen
1
Indirect Test: Detects antigen and/or Immunoglobulin (antibody) after its
reaction with antigen
A
A
N^ *-
J(
A
Preparation of Slides for inaiuno Fluorescence Studies
Direct Staining •
1. 30 sees, in 95f/0 ETOH - wash off with PBS in wash bottle (or
pour from bottle)
2. 5 rains, in PBS - 2X
3'. Wash off slide with FSS
H-. dry - except the tissue
5. Supply.FICA anti-sera
6. Incubate 30 mins. in moisture chamber
7. Repeat steps 2,3,^,5
8. Supply cover slips with buffered glycerine
Use cold PBS
Buffered glycerine - 20cc. glycerine
1 drop PBS
Indirect Staining Technique
TI Mark off area of tissue to be stained with, marker (ink pen)
2. Dip in 95% ETOH for 30 sees.
3. 5 mins. in PBS - 2X after rinsing slide with wash bottle of PBS
b. Wipe off slide around marked area
5. Add a drop of aniesera
6. Incubate 30 mins. in moisture chamber
7. 5 mins. in PBS - 2X
8. VJipe around marked area
9. Add one drop of fl. antisera
10. 30 mins. in moisture chamber - then rinse with rinse with squirt
bottle
11. PBS wash - 2X . • - - '
12. Rinse off with squirt bottle
13. Wipe around marked area
l^ f-. Coverslip with buffered glycerine • . . '
Fluorescent Antisera dilutions: Make dilutions with PBS, pH 7.^
Fluorescent antisera to mouse ganaaa globulin (made in goats)
Use diluted !•>
Human Fl. antisera
Use diluted 1:2
ABSORBED FLUORESCENT AKTISSRA
I cc. Sera
Add 10 mg. mouse liver powder
v
Sit for 3^' tiiins. at room temp.
Stir every 10 mins. with stick
Spin as hard as possible (5 mins.) X 3
,1. Use Reabsorbed antisera on tissue slides
1-A dil., 1:2 dil.
2. Examine slides for optimum staining dilution
ACRIDINE ORANGE STAINING TECHNIQUE
Fixation of slides;
ETOK-ether: ethyl alcohol(abs.)
1:1 for 15 isins.
dilute with
NaCl
8o*?<7 alcohol: 5 mins. (33-7 cc. > 40 cc.)
70% alcohol: 5 mins. (29.5 cc. ) ko cc.)
50 <& alcohol: 5 mins. (21.1 cc. > ko cc.)
Can store slides in Had before staining
Staining:
Acridine Orange: Dilute 1:10 with Mcllvaine buffer mixture,
pH 3.8 or Phosphate Buffered Saline (PBS) pH ^.6.
Filter raixture before using.
1. Immerse slides in diluted AO for 5 sees, with agitation.
2. Immerse slides for 12 sees, in 2^ ethanol in isotonic saline
(2 ml. ethanol + 93 ml. saline)
3. Rinse for 5 sees, in isotonic saline and coverslip wet-.
With dispopipette put drop of NaCl at edge of coverslip to keep
it wet. Store in petri dish.
Timing variations that give good results: Using PBS
5" in AO and 20" in 2# ETOH in NaCl
5" in AO and 12" in 2vfc ETOH in NaCl
3" in AO and 12" in 2'i ETOH in NaCl
Acridine Orange Staining
Phos-ohate Buffered Saline
p
Stock A:
Stock B:
PBS: for 1 liter (distilled KO)'
8.77 gns. KaCl
19,5 ml. Stock A
30.5 ml. Stock B
(See Reprints)
27.6 grams (to 1 liter)
35-6l grams (to 1 liter)
•Buffer Solution McLlvaine, pH 3.8
Sodium Phosphate
Citric Acid
Water, distilled..QS..
Bowie ide, ~L*js
10.08 grans
13.56 grams
1.0 Liter
5.0 ml.
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Fix in ••''-''- ;Ethanol - :
Wash in HO
Dry
100 ;'-'" Ethanol
95 ;:
95 -'
& '
70 ' ;
H '•" E Stain - 1 rain.
Acid OH - Dip rapidly
H20
H20
Ammonia
r- PROCEDURE FOR CYTOSCAN
 15 mins.
15. H20
;i6. 70';ETOH !x
17. Eosin - 25 sees.
18. 70^  OH
:i9- 60 v:f
:20. 95 "A
21. 100 f/C
•22. Dry slides
.23. Mount in riycerin
Wright's Stain; •
1. Stain same day smears are made
.2. Cover smear with Wright's Stain - let stand 2 mins. (do" not allow to
ppt. through evap.)
-3. Add equal amt. buffer sol'n. (pH 6.k)
Distribute over whole slide - none should run off edges
k. Stain and buffer.mixed by blowing on surface (mixture should show a
brassy sheen)
'5- Let stand 5 mins. • • -
•6. Wash stain - run stream HpO directly into center of slide for
30 sees.
7. Wipe off back of slide with cloth .
'8. Stand on end and let dry in air . .
9. . If stain ppts. cover slide with 95^ ETOH and wash immediately
;10. If stain is not deep enoughh, restain
'Gram Stain:
1. With pasteur pipet put a little of culture on slide
,2. Allow to air dry
3- Heat fix over flame (just until slide becomes hot )
A. Place slide on rach and flood with crystal violet
Leave on 1 min. Then shake off '• '„
'5. Wash off coaroletely with squirt bottle of H?0
.6. Add 95 & ETOH .
Leave on apprqx. 2-5 sees, (until blue stops coming out of the prep.)
Wash off immediately with PUO
7- Add safranin - leave on 30 sees.
Wash off and blot dry.
Preparation of Immunoelectrophoresis Plates
1. Dilute LKB buffer 1:^  (75:225) with d.Hp_0 ' (300 ml. total)
2. Heed l'l/2% Noble Agar Scl'n
Prepare by adding 4 1/2 gins, agar to the above 300 cc. buffer.
3- 10 mgms. of methiolate/lOOcc. '
•^. Put in boiling HpO (make a double boiler) until it goes into
sol'n, (^ 5 mins.). Shake inbetween. Cool for 1/2 hr. at 5o°C.
5. Number the slides and put in. plastic holder.
6. Put 12 cc. on each side of slide rack. Fill edges first and
. then slides.
7- Let set until hard. . . '
8. Put In metal holder and put in moisture chamber and refrigerate
until used.
LKB buffer: 65 gm. Na Acetate and 103 gra. Wa Barbitol
l6»..4 gm. Barbitol ——, .^ in 10 liters
••. (add to water) (Keep refrigerated)
Slides;.: Gelman slides 51^ 59 o^ any without frosted end will do.
Chamber; 700 ml. LKB put in each side of chamber. Wicks kept
in refrigerator. Drape them on top of ends of agar
slides and into troughs. With dispopipette wet wicks
until very wet.
Procedure for Immunoelectrpphoresis: . '
1. Cut holes and wells with punch set. Then suction agar out.of holes.
2.- Apply sample(s) to holes.
3. Place .agar slides in chamber and apply wicks to each end.
k. Run for lj-5-60 mins. at 250 volts pulling 12 MA.
5. Turn off maching and remove slides. Suction .agar from troughs.
6. Add antisera to wells (fill them) and let slides stand at room'
teruo. in moisture chamber overnight.
Macrophage Study Procedure;
1. Do four implants per study: one extra in case one mouse dies.
Day 0: day of implant
Day 1: day 1 after implant
Day 2: day 2 after implant ' .. •
Day 3: day 3 after implant
Each day an implant is removed and its contents studied
2. .1 ml. parasitised blood (P.b.) is injected into chamber with
a 26g. needle. &/at.&£>'** CMC) -£•£.*&..'
First rinse blood 2X in PBS and dilute 'to a pinl: ooluirion. .Then
count number of RBC's per .1 ml. Also determine parasitemia
from tail smears of mice parasitised blood was taken from.
Figure the number of parasited cells that wiTJ. be injected.
ftdtl 4, 'Jfr^c/.:'/.'_ <fl' */ '--'•'": '* 't*^-* •::• v-' & S/-.e '"'• • • ' * • ' • •
3. After the .1 ml. blood is injected into the chamber seal chamber
hole with glue. .Place implant into peritoneal cavity of mouse
using semi-sterile technique.
Things that can happen to alter results:
1. Volume of liquid change: f£parasitemia won't change
but number of RBC's will in a smaller volume.
2. Lysis of some of the cells.
3. Avoid placing chamber on a damp flat surface after removing
from the mouse as some of the fluid may be lost. Be sure
to place in a moisture chamber on sticks away from the
moist tissue paper.
4. When placing into peritoneal cavity of the mouse avoid
contacting chamber with alcohol or other antiseptic .
used to wipe mouse as cells might be killed if it is
absorbed into chamber.
5. 'Do not rupture sides of chamber when inserting and removing
from mouse.
After removing chamber from mouse cavity examine by withdrawing
fluid with 26g. needle and Ice. syringe and checking volume re-
covered. The vol. recovered from O.lcc. is around 0.06cc. Count
number of cells on hemacytometer.
(Fribrin usually forms in the chambers and heparin can be injected
into the mice when chambers are implanted to prevent this)
From the hetaacytomer. cell count figure how many RBC's were re-
covered out of the number injected. (Account for volume change)
.Macrophage study procedure (con'd)
Heparin injections to be given:
Day 0: .1 cc. intraperitoneally
Day 1: .15 (morning), .05 (afternoon)
Day 2: .1 cc. (morning)
In the macrophage study 8 to 12 mice will be used. There will be a control
group of mice (chambers will contain parasitised blood only) and a test
group (chambers will contain parasitised blood and raacrophages). Sach
mouse will have two chamber implants for a duplicate.
Preparing the macrophages: .
The macrophages are obtained from the ascites fluid formed in mice
injected with freund's adjuvent. ' •
Procedure: Inject 10 mice with 1 cc. complete Freund's adjuvent.
One week later inject mice again with incomplete Freund's
adjuvent. An ascites will form which can be drained
from the peritoneal cavity.
Mouse numbering
 system (mark
picric acid
Preparing and Testing Rabbit Anti-Mouse Serum
Injecting rabbits:
Obtain 1 1/2 - 2 cc. normal mouse blood'and centrifuge for
.10 rains. Remove serum and buffy coat and rinse red cells k-X in WaCl.
Dilute to k.o mis. and count number of RBC's/ml. on hemacytoiaeter.
Inject two rabbits with 0.5 cc. in each shoulder and each hip.
(Total of 4.0 ml. injected) Boost (repeat above procedure) for 3 to
k weeks (once a week) until rabbits have had sufficient time.to
produce a high level of antibody against the red cells of the mouse.
Bleeding rabbits: .
1. Remove rabbit from cage and place on table top. Wrap
securely in a cloth.
2. Shave outer edge of rabbits ear near the base and apply
vaseline. Shave tip of ear and apply xylene. . This will
cause irritation and the vein will engorge with blood.
3» With a sharp pointed razor blade nic the vein where the
vaseline was applied and collect blood in tubes. About 30 cc.
from an average size rabbit is good. • '.
k. After finishing collection unwrap rabbit and rinse xylene from
. the ear. Press ear where cut for several minutes until
bleeding stops.
5. Before'returning rabbit to cage be sure to remark rabbits
ear. • . -
Testing Activity of Serum: agglutination ability of rabbit anti-mouse serum
1. Inactivate the rabbit serum by heating at 56°C for 30 mins.
2. Bleed out a normal mouse and rinse the RBC's in .NaCl 2 X.
Put cells in 2 ml. Wad.
Add .1 cc. cells to each of 7 small tubes:
„ no antisera
3 .1 ml undil. antisera
4 .1 ml antisera (diluted 1:1 with WaCl) 1:2 dil.
5 .1 ml of 1:2 (dil. 1:1 with WaCl)' l:k dil.
6 1:8 dil.
7 .1 ml of 1:10 antisera (.1 cone, plus .9 PBS) 1:10 dil.
Look at agglutination immediately. Put in 37°C water bath
for 10 mins. and read again. Grade from 0 to
o:s?.
Culture Preparations
;iT-:?;{ccrrE PREPARATION • •
U JBlood—0.2 ml of phenol free hcparin por 10 nl whole blood
*!„ Divide blood to be used into sterilo Fisher tubes and cap.
.2. Centrifuge for tvro riirrates at 3500 G in a Fisher centrifuge. \
3. Remove the buffy coat and place in a Fishor tube containing anti A3 or
Anti H depending on blood type. .
a. Blood groups A, 3 or A3—use 0.25 nl Anti A3 plus 0.05 nl Anti H.
b. Blood group 0~uso 0.3 nil Anti H.
'^. Agglutinate red blood cells by inverting tubes approxir^tely 3 tir.os por
minute for two to five minutes.
;;5» Renovo agglutinated red cells by spinning for throe secorris at 1000 G
in a Fisher centrifuge. • .
6. Transfer the supernatant to a sterile r.eckran tubo and spin full spo*~<i
for 10 seconds in a reck-'uin centri.fur;e to ao'lutir.ate any reminL-K: rc-i colls..
'-•?». Discard the suiiorn-itant and gently reouspeixi tho colls in TCI9'? vit'h .70- A?
sorun, vnLth a Pasteur pipette, freeing tho leu'.'.ocytca fro:i tho clur:p».-:5 crlls.
• 8. Remove the residual red cells ;dth a one third speed, t-./o srcor.d spin.
Control speed by a transformer. Transfer tho sur^rrvitant, containin-.
leukocytes, and centrifuge at full speed for 10 seconds to wash out Anti A3
serun. Resuspend the sedinentcd leukocytes in 0.1 nl of noma?. AD
hunan serum and 0.1 nl of TC 199/20 .o A3 soru:n nediuri.
"9» Placo the solution on a three quarter-inch colurrm of
 :~lass beads contained
in a nylon-plumed plastic drinking straw. (The beads hava been precoatod
with l,j cum arabic and dried.)
10. Incubate at 37°C for two to three minutes.
;11. Flush out lymphocytes with 1.5 nl TC 199/A3 somn n-odiuni into a Fishor tube
and centrifuge at 1000 G for 2 ninutes.
12. Remove stipernatant and resuspend cells in approxirvitoly 1 nl of TC 199.
Centrifuge at 1000 G for 2 ninutes. ' -
13. Repeat wash once nore, • After renovin^ suporn-atant as conplct^ly an
possible, add 1 nl TC 199/20i A3 serum ncdia to tube and rosuspcrd colla.
1^. Do a cell count usin^ Unopette and henvacytorceter to do.tomino rra~hcr of ";
lymphocytes. Calculate $ of polys present. Cells are'then ready to bo
A* ' Po'cc-.'ccd nitcr:en (F,-i"-i). Reconstitute contents of vial with 5 "1 of sterile
distilled water, /mount to bo usrci i.~ tho equivalent of 0.1 nl per 10 nl
of culture fluid. Adjust according to si~.o of culture to bo sot up.
,1. Usinc stcrilo Fisher tubes, add 0.5 rsl TC 19?/20> A3 sorun medium which '
contains 0,05 ral F'.u-t solution. . •
2, Add cell suspension to provide 10 X 10 lymphocytes per culture. Anount
must bo loss th.in 0,5.^ 1 or tho tubes will bo over filled..
3. C.ip Cultures and put on rotator in 37°C incubator until tir.o of harvest,
-B» Concannvalin A (Con A). Reconstitute contents of vial with 25 ^1 sterile,,
distilled vater. Ar.ount to be used is tho cqniv.ilont of 10 U': por 1 X 10
lymphocytes, .'Idjust according to size of culture to be set up.
'M. Usin.3 sterile Fisher tubes, add 0,5 nl 1C 199/20'• A3 sorun containing
1.0 u.,3 Con A.
[4.
2tt Add coll suspension to provide 10 X 10 lynphocytos per culture.
;3» Cap culturos and put on rotator in 37°C incubator until tino of harvest,
;;CS Unstimulated
.„;!. Usin^  sterile Fisher tubes, add 0.5 nil TC 199 with 20$-AM aorun. .
A
 ' /• '
..2. Add coll suspension to provide 1.0 X lO*1" lymphocytes per culture.
3. Cap cultures .and put on rotator in J?°C incub.itbr until tino of harv'or.t.
•TDLRVEST PRCCSDURS '
'il,» CentriiMse cultures for 2 minutes at 1000 G in the.Fisher centrifuge,
.?2.o .Renovc sxipernat-int, r.nd resuspend colls in buffered sr.lino.
"3» "Centrifuge at 1000 G for t--7o riirnates, and then repent vr.sh ono more t.ino.
-.4« Resuspend calls in buffered saline to r;ive the desired cell concentration on tho
•slide. Tho amount of saline may vary doperxient on tho number of colls prercnt.
*-5» Apply colls to quarts slide by sproadinr in a circle appro.clnatoly the 3ir,o of
the cover slip, Lot slides air dry conpletoly, -
60 .Fix slides in absolute othanol for 15 minutes. Check slide to avoid evaporation
of the alcohol.
7o Let dry and apply quarts cover slip with Zoiss inversion glycerine. Seal with
fingernail polish^
APPENDIX
VII. Ultrastrueture of Lymphocytes from a Child with
Severe Combined Irmiunodeficiency. 1973. Abstract
to be published by the Texas Society for Electron
Microscopy.
^STRUCTURE OF LYMPHOCYTES FROM A CHILD WITH SEVERE COMBINED IMMLfNODEFICIENCY.
aid Jordan, M.S.1, B.^Sue Crisvellt Ph.D.2, Mary Ann South* M.D.2, and
n h. Montgomery, M.D.-, Northrop Services, Inc.i, and Baylor College of
.'Loins'-'.
;ph.o.cytes from a male infant delivered by C-section and placed into a germfree
dronrrisno have been examined by electron microscopy (EM). The child has a
;-linked severe combined immunodeficiency. At monthly intervals for 9 months,
;ii of vhole blood from the subject was obtained and the buffy coat fixed for
sour in 3% glutaraldehyde in 0.1M PES (pK 7-3), post-fixed for 1 hour in 1%
nic ".'tetroxide in 0.1M PBS, and embedded in epon-araldite. Sections were cut
-an ultramicrotome, stained with lead citrate and uranyl acetate, and the
iiph.o.cytes examined at 80KV. The cells were atypical, having a very sparse
to'pla-sm with little rough endoplasmic reticulum (ER) but abundant smooth ER. •
e nuclear membrane was pulled away from the nuclear space, and no evidence
nuclear pores or aggregated ribosomes were found. Mitochondria were intact.
peered injections of KLH and typhoid vaccine, and skin grafting during the
month period yielded no significant observable change in the fine structure
frhe.,,subject' s lymphocytes. At 11 months, the subject was given transfer
ctor, a substance reported to stimulate uncommitted T (thymic) lymphocytes,
iio'tfing repeated injections of this material, the original cell type was
i..11 present but a new type of lymphocyte was also observed by EM examination,
e -new cell type is smaller than normal lymphocytes, has a more dense cytoplasm,
:
.KK aggregated ribosomes, detectable amounts of rough EH and more intact nu-
:iu" membranes. This new type could represent a small population of uncommitted
>2l.ls responding to the stimulant (transfer factor).- (Supported by NASA
'ii
itract NASJ?-13QQ.J iNASA grant NCR kh-OQ3-Ohk, and CRC grant FR-00188 ahd
•A KU-AI-2332G. )
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VIII. Changing Populations of Peripheral Blood
Lymphocytes in a Gnotobiotic Child with
Combined Immune Deficiency. 1973. Abstract
to be published by the Leukocyte Culture
Conference to be held in Sweden in August, 1973.
CHANGING POPULATIONS OF PERIPHERAL BLOOD LYMPHOCYTES IN A
GNOT08IOTIC CHILD WITH COMBINED IMMUNE DEFICIENCY. .
B. Sue Criswell , Stephen L. Kimzey, Mar.y A. South, and
John R. Montgomery. Baylor College of Medicine, Clinical Research
Center of Texas Children's Hospital, and Manned Spacecraft
Center—NASA, Houston, Texas
A male infant delivered by C-section and placed into a
germfree environment has been studied for lymphocytic responses
by a number of techniques. The child has a sex-linked severe
combined immunodeficiency which was confirmed by initial
immunologic studies consisting of PHA, PWM, and antigenic stimu-
lation of peripheral lymphocytes, quantitative immunoglobulins,
administration of standard and experimental antigens (KLH) and
skin grafting. For the last year the lymphocyte population of
this subject has been studied by microspectrophotometry for
changes in nuclear and cytoplasmic organization. In three
serial studies, peripheral lymphocytes changed following an
immunization of the subject with such agents as KLH and typhoid
vaccine. Alterations in cellular size and extinction patterns
following hematoxylin and eosin staining were detected using a
computer-controlled Zeiss Scanning Microscope Photometer. Prior
.to the immunologic challenge the cells were large with relatively
'low extinction ranges and resembled immature cell types. Within
'L '•'£! pi I'*" 4-U-~. s+ f^l ~\ r* v*("i<-rsfn(-,*l^^-l rs m^v*/-\ ins\v*rc> -3 1 r\rsrMil^T-nr-, n • f\f
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lymphocytes in size and extinction patterns. These data were
also analyzed by a multidimensional clustering computer routine
for detection of subpopulations of.lymphocytes. Comparisons
were made with patterns of cells from normal, control individuals
In contrast to these changes, lymphocytic cultures taken at • '
each of the same sampling periods did not respond to any stimuli
with increased uptake of radio!abeled thymidine. Since
structural changes in populations of cells were observed,
scanning microspectrophotometry coupled with computerized
classification of cell types based on extinction patterns appears
to be a promising technique for differentiating a new level of
response of lymphocytes. It may also yield useful information
concerning the level of defect in a non-functional population
of cells.
